Clinical Trial Update: EMD 273066 in Patients With Recurrent EpCAM Positive Ovarian, Prostate, Colorectal or Non-small Cell Lung Cancers When First Given Cyclophosphamide [Phase 1]

View source ↗

Summary

Phase 1 trial evaluating EMD 273066 in EpCAM-positive recurrent ovarian, prostate, colorectal, or non-small cell lung cancer when first treated with cyclophosph…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colorectal Cancer
• Non-small Cell Lung Cancer
• Ovarian Cancer
• Prostate Cancer

Drugs mentioned

• CYCLOPHOSPHAMIDE (Cyclophosphamide)
• EMD 273066

Snippet

Sponsor: EMD Serono | Conditions: Ovarian Cancer, Colorectal Cancer | Phase 1 | Status: COMPLETED